Arvinas reports Phase 1 Parkinson’s trial data showing ARV-102-linked gains in oculomotor measure
Bitget2026/10/07 11:02Arvinas presented final Phase 1 data on ARV-102 in Parkinson’s disease at the 2026 MDS meeting in Seoul. Results supported central nervous system exposure, LRRK2 degradation, improved objective eye-movement function, with biomarker shifts consistent with disease-relevant pathway modulation. Exploratory analyses linked biomarker reductions with eye-movement changes, supporting continued clinical evaluation despite no efficacy design. The 28-day study tested oral dosing versus placebo in 24 patients, informing next-step development for LRRK2-related neurodegenerative diseases. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arvinas Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610070700PRIMZONEFULLFEED9841091) on October 07, 2026, and is solely responsible for the information contained therein.
- Arvinas presented final Phase 1 data on ARV-102 in Parkinson’s disease at the 2026 MDS meeting in Seoul.
- Results supported central nervous system exposure, LRRK2 degradation, improved objective eye-movement function, with biomarker shifts consistent with disease-relevant pathway modulation.
- Exploratory analyses linked biomarker reductions with eye-movement changes, supporting continued clinical evaluation despite no efficacy design.
- The 28-day study tested oral dosing versus placebo in 24 patients, informing next-step development for LRRK2-related neurodegenerative diseases.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
SNT Holdings, Related Party Raise Combined Stake in SNTEnergy to 55.75% From 52.75%
Cold wave and rising fuel costs drive electricity prices in northeastern Japan and Tokyo to a four-year high
Japan's spot electricity prices surged to multi-year highs over the weekend.
Google (GOOGL.US) warns that new Australian cybersecurity regulations may cut off minors' access to Gmail
Google stated that a new cybersecurity bill in Australia could prevent minors from using Gmail.
Canaccord Genuity: Lowers Oklo's target price to $66
Crypto prices
More
